External ocular herpesvirus infections in immunodeficiency

References

• Sullender W. M., Miller J. L., Yasukawa L. L., Bradley J. S., Black S. B., Yeager A. S., Arvin A. M. Humoral and cell-mediated immunity in neonates with herpes simplex virus infection. J. Infect. Pis. 1987; 155: 28–37
   Google Scholar
• Chilmonczyk B. A., Levin M. J., Duffy R., Hayward A. R. Characterization of the human newborn response to herpesvirus antigen. J. Immunol. 1985; 134: 4184–4188
   PubMed Web of Science ®Google Scholar
• Burchett S. K., Westall J., Mohan K., Corey L., Wilson C. B. Ontogeny of neonatal mononuclear cell transformation and interferon gamma production after herpes simplex virus stimulation. Clin. Res. 1986; 34: 129
   Google Scholar
• Brick D. C., Oh J. O., Sicher S. E. Ocular lesions associated with dissemination of type 2 herpes simplex virus from skin infection in newborn rabbits. Invest. Ophthalmol. Vis. Sci. 1981; 21: 681–688
   PubMed Web of Science ®Google Scholar
• Nahmias A. J., Visintine A. M., Caldwell D. R., Wilson L. A. Eye infections with herpes simplex viruses in neonates. Surv. Ophthalmol. 1976; 21: 100–105
   PubMedGoogle Scholar
• el Azazi M., Malm G., Forsgren M. Late ophthalmologic manifestations of neonatal herpes simplex virus infection. Am. J. Ophthalmol. 1990; 109: 1–7
   PubMed Web of Science ®Google Scholar
• Metcalf J. F., Kaufman H. E. Herpetic stromal keratitis-evidence for cell mediated immunopathogenesis. Am. J. Ophthalmol. 1976; 82: 827–834
   PubMed Web of Science ®Google Scholar
• Rager-Zisman B., Quan P. C., Rosner M., Moller J. R., Bloom B. R. Role of NK cells in protection of mice against herpes simplex virus-1 infection. J. Immunol. 1987; 138: 884–888
   PubMed Web of Science ®Google Scholar
• Biron C. A., Byron K. S., Sullivan J. L. Severe herpesvirus infections in an adolescent without natural killer cells. N. Engl. J. Med. 1989; 320: 1731–1735
   PubMed Web of Science ®Google Scholar
• Kohl S., West M. S., Prober C. G., Sullender W. M., Loo L. S., Arvin A. M. Neonatal antibody-dependent cellular cytotoxic antibody levels are associated with the clinical presentation of neonatal herpes simplex virus infection. J. Infect. Dis. 1989; 100: 770–776
   Google Scholar
• Metcalf J. M., Koga J., Chattejee S., Whitley R. J. Passive immunization with monoclonal antibodies against herpes simplex virus glycoproteins protects mice against herpetic ocular disease. Curr. Eye Res. 1987; 6: 173–177
   PubMed Web of Science ®Google Scholar
• Raizman M. B., Foster C. S. Passive transfer of anti-HSV-1 IgG protects against stromal keratitis in mice. Curr. Eye Res. 1988; 7: 823–829
   PubMed Web of Science ®Google Scholar
• Lausch R. N., Oakes J. E., Metcalf J. F., Scimeca J. M., Smith L. A., Robertson S. M. Quantitation of purified monoclonal antibody needed to prevent HSV-1 induced stromal keratitis in mice. Curr. Eye Res. 1989; 8: 499–506
   PubMed Web of Science ®Google Scholar
• Shimeld C., Hill T. J., Blyth W. A., Easty D. L. Passive immunization protects the mouse eye from damage after herpes simplex virus infection by limiting spread of virus in the nervous system. J. Gen. Virol. 1990; 71: 681–687
   PubMed Web of Science ®Google Scholar
• Tullo A. B., Shimeld C., Blyth W. A., Hill T. J., Easty D. L. Spread of virus and distribution of latent infection following ocular herpes simplex in the non-immune and murine mouse. J. Gen. Virol. 1982; 63: 95–101
   PubMed Web of Science ®Google Scholar
• Lee S. F., Laycock K. A., Pepose J. S. Characterization of a murine model of recurrent herpetic keratitis. Invest. Ophthalmol. Vis. Sci. 1990; 31: 220, (Suppl.)
   Google Scholar
• Stevens J. G., Cook M. L. Maintenance of latent herpetic infection: an apparent role for antiviral IgG. J. Immunol. 1974; 113: 1685–1693
   PubMed Web of Science ®Google Scholar
• Scott T. F.M. Epidemiology of herpetic infections. Am. J. Ophthalmol. 1957; 43: 134–141
   PubMed Web of Science ®Google Scholar
• Abghari S. Z., Stulting R. D. Variation in the number of sites of latency of herpes simplex virus in trigeminal ganglia of inbred mice. Curr. Eye Res. 1988; 7: 1155–1161
   PubMed Web of Science ®Google Scholar
• Hirsch M. S. Herpes group in the compromised host. Clinical Approach to Infection in the Compromised Host, R. H. Rubin, L. S. Young. Plenum Publishers, New York 1988; 347–365
   Google Scholar
• Kaufman H. E., Brown D. C., Ellison E. M. Recurrent herpes in rabbits and man. Science 1967; 156: 1628–1629
   PubMed Web of Science ®Google Scholar
• Spurney R. V., Rosenthal M. S. Ultraviolet-induced recurrent herpes simplex virus keratitis. Am. J. Ophthalmol. 1972; 73: 609–610
   PubMed Web of Science ®Google Scholar
• Haruta Y., Rootman D. S., Xie L., Kiritoshi A., Hill J. M. Recurrent HSV-1 corneal epithelial lesions induced by cyclophosphamide and dexamethasone in latency infected rabbits. Invest. Ophthalmol. Vis. Sci. 1989; 30: 371–376
   PubMed Web of Science ®Google Scholar
• Stroop W. G., Schaefer D. C. Severity of experimentally reactivated herpetic eye disease is related to the neurovirolence of the latent virus. Invest. Ophthalmol. Vis. Sci. 1987; 28: 229–237
   PubMed Web of Science ®Google Scholar
• Stroop W. G., Schaefer D. C. Production of encephalitis restricted to the temporal lobes by experimental reactivation of herpes simplex virus. J. Infect. Pis. 1986; 153: 721–731
   Google Scholar
• Shimeld C., Hill T. J., Blyth W. A., Easty D. L. Reactivation of latent infection and induction of recurrent herpetic eye disease in mice. J. Gen. Virol. 1990; 71: 397–404
   PubMed Web of Science ®Google Scholar
• Foster C. S., Opremcak E. M., Rice B., . Immunogenetic control of ocular responses to herpes simplex virus. The Cornea: Transactions of the World Congress on the Cornea III, H. D. Cavanagh, et al. Raven Press, Ltd., New York 1988; 413–421
   Google Scholar
• Easterbrook M., Wilkie J., Colemen V., Dawson C. R. The effect of topical corticosteroids on the susceptibility of immune animals to reinoculation with herpes simplex. Invest. Ophthalmol. 1973; 12: 181–189
   PubMedGoogle Scholar
• Gebhart B. M., Hill J. M. T lymphocytes in the trigeminal ganglia of rabbits during corneal HSV infection. Invest. Ophthalmol. Vis. Sci. 1988; 29: 1683–1691
   PubMed Web of Science ®Google Scholar
• Stevens J. G., Wagner E. K., Devi-Rao G. B., Cook M. L., Feldman L. T. RNA complementary to a herpesvirus alpha gene is prominent in latently infected neurons. Science 1987; 235: 1056–1059
   PubMed Web of Science ®Google Scholar
• Croen K. D., Ostrove J. M., Dragovic L. J., Smialek J. E., Straus S. E. Latent herpes simplex virus in trigeminal ganglia: Detection of an immediate early gene “anti-sense” transcript by in situ hybridization. N. Engl. J. Med. 1987; 317: 1427–1432
   PubMed Web of Science ®Google Scholar
• Rock D. L., Nebsurn A. B., Ghiasi H., Ong J., Lewis T. L., Lokensgard J. R., Wechsler S. L. Detection of latency related viral RNAs in trigeminal ganglia of rabbits latently infected with herpes simplex virus type 1. J. Virol. 1987; 61: 3820–3826
   PubMed Web of Science ®Google Scholar
• Leib D. A., Bogard C. L., Kosz-Vrenchak M., Coen D. M., Knipe D. M., Schaffer P. A. A deletion mutant of the latency associated transcript of herpes simplex virus type 1 reactivates from the latent state with reduced frequency. J. Virol. 1989; 63: 2893–2900
   PubMed Web of Science ®Google Scholar
• Hill J. M., Sedarati F., Javier R. T., Wagner E. K., Stevens J. G. Herpes simplex virus latent phase transcription facilities in vivo reactivation. Virology 1990; 174: 117–125
   PubMed Web of Science ®Google Scholar
• de la Maza M. S., Wells P. A., Foster C. S. Cyclic nucleotides modulation of herpes simplex virus latency and reactivation. Invest. Ophthalmol. Vis. Sci. 1989; 30: 2154–2159
   PubMed Web of Science ®Google Scholar
• Leib D. A., Nadeau K. C., Schaffer P. A. Regulation of the latency-associated transcript (LAT) of herpes simplex virus type 1. Invest. Ophthalmol. Vis. Sci. 1990; 31: 313, (Suppl.)
   PubMedGoogle Scholar
• Jones C., Delhon G., Bratanich A., Kutish G., Rock D. Analysis of the transcriptional promoter which regulates the latency-related transcript of bovine herpesvirus 1. J. Virol. 1990; 64: 1164–1170
   PubMed Web of Science ®Google Scholar
• Hill T. J., Blyth W. A. An alternative theory of herpes simplex recurrent and a possible role for prostaglandins. Lancet 1976; 1: 397–398
   PubMed Web of Science ®Google Scholar
• Meyers-Elliott R. H., Chitjian P. A., Billups C. B. Effects of cyclosporine A on clinical and immunological parameters in herpes simplex keratitis. Invest. Ophthalmol. Vis. Sci. 1987; 28: 1170–1180
   PubMed Web of Science ®Google Scholar
• Boisjoly H. M., Woog J. J., Pavan-Langston D., Park N. Prophylactic topical cyclosporine in experimental herpetic stromal keratitis. Arch. Ophthalmol. 1984; 102: 1804–1807
   PubMedGoogle Scholar
• Korsager B., Spencer E. S., Mordhobt C. H., Anderson H. Z. Herpesvirus hominis infections in renal transplant recipients. Scand. J. Infect. Dis. 1975; 7: 11–19
   PubMed Web of Science ®Google Scholar
• Pass R. F., Whitley R. J., Whelchel J. D., Diethelm A. G., Reynolds D. W., Alford C. A. Identification of patients with increased risk of infection with herpes simplex virus after renal transplantation. J. Infect. Dis. 1979; 140: 487–492
   PubMed Web of Science ®Google Scholar
• Howcroft M. J., Breslin C. W. Herpes simplex keratitis in renal transplant recipients. Can. Med. Assoc. J. 1981; 124: 292–294
   PubMed Web of Science ®Google Scholar
• Easty D. L. Manifestations of immunodeficiency diseases in ophthalmology. Trans. Ophthal. Soc. U.K. 1977; 97: 8–17
   PubMedGoogle Scholar
• Hirst L. W., Jabs D. A., Tutschka P. J., Green W. R., Santos G. N. The eye in bone marrow transplantation. I. Clinical study. Arch. Ophthalmol. 1983; 101: 580–584
   PubMedGoogle Scholar
• Jack M. K., Hicks J. D. Ocular complications in high-dose chemoradiotherapy and marrow transplantation. Ann. Ophthalmol. 1981; 13: 709–711
   PubMedGoogle Scholar
• Pass R. F., Long W. K., Whitley R. J., Soong S.-J., Diethelm A. G., Reynolds D. W., Alford C. A., Jr. Productive infection with cytomegalovirus and herpes simplex virus in renal transplant recipients: Role of source of kidney. J. Infect. Dis. 1978; 137: 556–563
   PubMed Web of Science ®Google Scholar
• Rand K. H., Rosmussen L. E., Pollard R. B., Arvin A., Merigan T. C. Cellular immunity and herpesvirus infections in cardiac-transplant patients. N. Engl. J. Med. 1976; 296: 1372–1377
   Web of Science ®Google Scholar
• Foster A., Sommer A. Corneal ulceration, measles, and childhood blindness in Tanzania. Br. J. Ophthalmol. 1987; 71: 331–343
   PubMed Web of Science ®Google Scholar
• Liesegang T. J. Epidemiology of ocular herpes simplex. Natural history in Rochester, MN, 1950 through 1982. Arch. Ophthalmol. 1989; 107: 1160–1165
   PubMed Web of Science ®Google Scholar
• Amman A. J., Hong R. Cellular immunodeficiency disorders. Immunologic Disorders in Infants and Children, E. R. Stiehm, V. A. Fulgineti. W.B. Saunders Co., Philadelphia 1973; 156–171
   Google Scholar
• Fan C. C., Shimomura Y., Inoue Y., Watanabe H., Iwaski N., Matsuda M., Manabe R., Imara M., Harada S., Yanaghi K. A case of simultaneous bilateral herpetic epithelial keratitis. Jpn. J. Ophthalmol. 1989; 33: 120–124
   PubMed Web of Science ®Google Scholar
• Holland G. N., Pepose J. S., Dinning W. J. Ophthalmic disorders associated with selected primary and acquired immunodeficiency diseases. Duane's Clinical Ophthalmology, W. Tasman, E. A. Jaeger. J.B. Lippincott, Philadelphia 1989; 1–21
   Google Scholar
• Hegab S. M., Sheriff S. M.M., El-Aasar E. S.M., Lashin E. Z. Herpetic stromal keratitis in congenital dysgamma globulinemia. Cornea 1989; 8: 102–105
   PubMed Web of Science ®Google Scholar
• Shuler J. D., Engstrom R. E., Holland G. N. External ocular disease and anterior segment disorders associated with AIDS. Int. Ophthalmol. Clin. 1989; 29: 98–104
   PubMedGoogle Scholar
• McLeish W., Pflugfelder S. G., Crouse C., Rabinowitz S., Miller D., Hill E. L., Atherton S. Interferon treatment of herpetic keratitis in a patient with acquired immunodeficiency syndrome. Am. J. Ophthalmol. 1990; 109: 93–95
   PubMed Web of Science ®Google Scholar
• Lausch R. N., Kleinschrodt W. R., Monteiro C., Kayes S. G., Qakes J. E. Resolution of HSV corneal infection in the absence of delayed-type hypersensitivity. Invest. Ophthalmol. Vis. Sci. 1985; 26: 1509–1515
   PubMed Web of Science ®Google Scholar
• Newell C. K., Martin S., Sendele D., Mercadal C. M., Rouse B. T. Herpes simplex virus-induced stromal keratitis: role of T-lymphocyte in immunopathology. J. Virol. 1989; 63: 769–775
   PubMed Web of Science ®Google Scholar
• McLeish W., Rubsamen P., Atherton S. S., Streilein J. S. Immunobiology of Langerhans cells on the ocular surface. II. Role of central corneal Langerhans cells in stromal keratitis following experimental HSV-1 infection in mice. Reg. Immunol. 1989; 2: 236–243
   PubMedGoogle Scholar
• Feldman S., Hughes W. T., Daniel C. B. Varicella in children with cancer: Seventy-seven cases. Pediatrics 1975; 56: 388–397
   PubMed Web of Science ®Google Scholar
• Atkinson K., Storb R., Prentice R. L., Welden P. L., Witherspoon R. P., Sullivan K., Noel D., Thomas E. D. Analysis of late infections in eighty-nine long term survirors of bone marrow transplantation. Blood 1979; 53: 720–731
   PubMed Web of Science ®Google Scholar
• Weigle K. A., Grose C. Molecular dissection of the humoral immune response to individual varicella-zoster virus proteins during chickenpox, quiescence, re-exposure and reactivation. J. Infect. Dis. 1987; 149: 741–748
   Google Scholar
• Giller R. H., Bowden R. A., Levin M. J., Walker L. J., Tubergen D. G., Hayward A. R. Reduced cellular immununity to varicella zoster virus during treatment for acute lymphoblastic leukemia of childhood: In vitro studies of possible mechanisms. J. Clin. Immunol. 1986; 6: 472–479
   PubMed Web of Science ®Google Scholar
• Lux S. E., Johnston R. B., Jr., August C. S., Say B., Penchaszadeh V. B., Rosen F. S., McKusick V. A. Chronic neutropenia and abnormal cellular immunity in cartilage-hair hypoplasia. N. Engl. J. Med. 1970; 282: 231–236
   PubMed Web of Science ®Google Scholar
• Zaia J. A., Levin M. J., Preblud S. R., Leszcynski J., Wright G. G., Ellis R. JU., Curtis A. C., Valerio M. A., LeGore J. Evaluation of varicella-zoster infections in immunosuppressed patients. J. Infect. Dis. 1983; 147: 737–743
   PubMed Web of Science ®Google Scholar
• Gershon A. A., Steinberg S. P., Gelb L. Live attenuated varicella vaccine use in immunocompromised children and adults. Pediatrics 1986; 78: 757–762
   PubMed Web of Science ®Google Scholar
• Gelb L. D., Dohner D. E., Gershon A. A., Steinberg S. P., Waner J. L., Takahashi M., Dennehy P. H., Brown A. E. Molecular epidemiology of live, attenuated varicella virus vaccine in children with leukemia and in normal adults. J. Infect. Dis. 1987; 155: 633–640
   PubMed Web of Science ®Google Scholar
• Jura E., Chadwick E. G., Josephs S. H., Steinberg S. P., Yogev R., Gershon A. A., Krasinski K. M., Borkowsky W. Varicella-zoster virus infections in children infected with human immunodeficiency virus. Ped. Infect. Dis. J. 1989; 8: 586–590
   PubMed Web of Science ®Google Scholar
• Paryani S. G., Arvin A. M. Intrauterine infection with varicella-zoster virus after maternal varicella. N. Engl. J. Med. 1986; 314: 1542–1545
   PubMed Web of Science ®Google Scholar
• Lambert S. R., Taylor D., Kriss A., Holzel H., Heard S. Ocular manifestations of the congenital varicella syndrome. Arch. Ophthalmol. 1989; 107: 52–56
   PubMedGoogle Scholar
• Ragozzino M. W., Melton L. J., III, Kurland L. T., Chu C. P., Perry H. O. Population-based study of herpes zoster and its sequelae. Medicine 1982; 61: 310–316
   PubMed Web of Science ®Google Scholar
• Burke B. L., Steele R. W., Beard O. W., Wood J. S., Cain T. D., Marmer D. J. Immune responses to varicella-zoster in the aged. Arch. Intern. Med. 1982; 142: 291–293
   PubMed Web of Science ®Google Scholar
• Brunell P. A., Gershon A. A., Uduman S. A., Steinberg S. Varicella-zoster immunoglobulins during varicella, latency and zoster. J. Infect. Dis. 1975; 132: 49–54
   PubMed Web of Science ®Google Scholar
• Straus S. E., Ostrove J. M., Inchauspe G., Felser J. M., Freifeld A., Croen K. D., Sawyer M. A. Varicella-zoster virus infections. Biology, natural history, treatment, and prevention. Ann. Int. Med. 1988; 108: 221–237
   PubMed Web of Science ®Google Scholar
• Edgerton A. E. Herpes zoster ophthalmicus. Report of cases and review of literature. Arch. Ophthalmol. 1945; 34: 40-–62; 114–153
   Google Scholar
• Yamada K., Harjasaka S., Yamamoto Y., Setogawa T. Cutaneous eruption with or without ocular complications in patients with herpes zoster involving the trigeminal nerve. Graefe's Arch. Clin. Exp. Ophthalmol. 1990; 228: 11–14
   Web of Science ®Google Scholar
• Jabs D. A., Schachat A. P., Liss R., Knox D. L., Michels R. G. Presumed varicella zoster retinitis in immunocompromised patients. Retina 1987; 7: 9–13
   PubMed Web of Science ®Google Scholar
• Arvin A. M., Pollard R. B., Rasmussen L. E., Merigan T. C. Cellular and humoral immunity in the pathogenesis of recurrent herpes viral infections in patients with lymphoma. J. Clin. Invest. 1980; 65: 869–878
   PubMed Web of Science ®Google Scholar
• Stevens D. A., Merigan T. C. Zoster immune globulin prophylaxis of disseminated zoster in compromised hosts: a randomized trial. Arch. Intern. Med. 1980; 140: 52–54
   PubMed Web of Science ®Google Scholar
• Grose C., Giller R. H. Varicella-zoster virus infection and immunization in the healthy and the immunocompromised host. CRC Crit. Rev. Oncol. Hematol. 1988; 8: 27–64
   PubMed Web of Science ®Google Scholar
• Meyers J. D., Flournoy N., Thomas E. D. Cell-mediated immunity to varicella-zoster virus after allogeneic marrow transplantation. J. Infect. Dis. 1980; 141: 479–487
   PubMed Web of Science ®Google Scholar
• Sandor E. V., Millman A., Croxson T. S., Mildvan D. Herpes zoster ophthalmicus in patients at risk for the acquired immune deficiency syndrome (AIDS). Am. J. Ophthalmol. 1986; 101: 153–155
   PubMed Web of Science ®Google Scholar
• Kestelyn P., Stevens A. M., Bakkars D., Rouvroy D., Van de Perre P. Severe herpes zoster ophthalmicus in young African adults: a marker for HTLV-III seropositivity. Br. J. Ophthalmol. 1987; 71: 806–809
   PubMed Web of Science ®Google Scholar
• Cole E. L., Meisler D. M., Calabrese L. H., Holland G. N., Mondino B. J., Conant M. A. Herpes zoster ophthalmicus and acquired immune deficiency sundrome. Arch. Ophthalmol. 1984; 102: 1027–1029
   PubMed Web of Science ®Google Scholar
• Melbye M., Grossman R. J., Goedert J. J., Eyster M. E., Biggar R. J. Risk of AIDS after herpes zoster. Lancet 1987; i: 728–730
   Google Scholar
• Colebunders R., Mann J. M., Francis H., Kapha B., Izaley L., Ilwaya M., Kakonde N., Quinn T. C., Curran J. W., Piot P. Herpes zoster in African patients: a clinical predictor of human immunodeficiency infection. J. Infect. Dis. 1988; 157: 314–318
   PubMed Web of Science ®Google Scholar
• Engstrom R. E., Holland G. N. Chronic herpes zoster virus keratitis associated with the acquired immunodeficiency syndrome. Am. J. Ophthalmol. 1988; 105: 556–559
   PubMed Web of Science ®Google Scholar
• Ambrus J. L., Poiesz B. J., Lillie M. A., Stadler I., Di Berardino L. A., Chadha K. C. Interferon and interferon inhibitor levels in patients infected with varicella-zoster virus, acquired immunodeficiency syndrome-related complex, or Kaposi's sarcoma, and in normal individuals. Am. J. Med. 1989; 87: 405–407
   PubMed Web of Science ®Google Scholar
• Pahwa S., Biron K., Lim W., Swenson P., Kaplan M. H., Sadick N., Pahwa R. Continuous varicella-zoster virus infection associated with acyclovir resistance in a child with AIDS. JAMA 1988; 260: 2879–2882
   PubMed Web of Science ®Google Scholar
• Jacobson M. A., Berger T. G., Fikrig S., Becherer P., Moohr J. W., Stanat S. C., Biron K. K. Acyclovir-resistant varicella-zoster virus infection after chronic oral acyclovir therapy in patients with the acquired immunodeficiency syndrome (AIDS). Ann. Int. Med. 1990; 112: 187–191
   PubMed Web of Science ®Google Scholar
• Junker K., Amstorp C., Nielsen C. M., Hansen N. E. Re-infection with varicella-zoster virus in immunocompromised patients. Curr. Probl. Dermatol. 1989; 18: 152–157
   PubMedGoogle Scholar
• Kobayashi S., Ichinohe S., Okabe N., Tatsuzawa O. Varicella-zoster virus infection in chronic granulomatous disease. Ped. Infect. Dis. J. 1988; 7: 809–810
   PubMed Web of Science ®Google Scholar